Join us over coffee and a continental breakfast for a discussion on “State Opioid Taxes: Economic & Health Policy Implications” featuring Alex Brill, Matrix Global Advisors, to address the burdens of the opioid epidemic on states and potential policy solutions.
Alex Brill is the founder and CEO of Matrix Global Advisors (MGA). Prior to founding MGA in 2007, Alex was the policy director and chief economist for the House Committee on Ways and Means, where he worked from 2002 to 2007. At the Ways and Means Committee, Alex directed policy development and led negotiations on a variety of tax, health, pension, and trade matters. Prior to his time on Capitol Hill, he served on the staff of the White House Council of Economic Advisers.
Alex has testified numerous times before Congress and has served as an expert witness and litigation consultant in both tax and pharmaceutical patent litigations. He has written and consulted on small-molecule generic drug competition, drug pricing, Part B reimbursement, generic drug labeling requirements, disease management, and the economic consequences of obesity and obesity mitigation, among other issues. Alex is currently a resident fellow at the American Enterprise Institute.
Click here to watch the Facebook Live video of the briefing.